| 摘要 |
<p>The present invention relates to novel human antibodies targeted against the human HER4 receptor. More particularly, the present invention relates to human antibodies that selectively bind to the extracellular domain of the human HER4 receptor and to the use thereof as medicament, in particular for preventing or treating cancer.</p> |
